MMBC POWDER

$55$1,265

Description MMBC POWDER Physical State Powder Packaging Type As per your request Purity 99% API Form Powder MMBC POWDER Minimum Order Quantity 10 Gram Product description: MMBC POWDER Molecular Formula: C15H20CINO3 MMBC POWDER Purity: 99% Description: White powder Specification: USP28/BP2003 Packing: 1kg/aluminum foil bag We are an experienced supplier in this field, we have safe […]

Clear

Description
MMBC POWDER Physical State
Powder
Packaging Type
As per your request
Purity
99%
API Form
Powder
MMBC POWDER Minimum Order Quantity
10 Gram
Product description:

MMBC POWDER Molecular Formula: C15H20CINO3
MMBC POWDER Purity: 99%
Description: White powder
Specification: USP28/BP2003
Packing: 1kg/aluminum foil bag

We are an experienced supplier in this field, we have safe and fast delivery method,also our products quality and price are very competitive, any inquiry,Feel free to contact us at info

MPHP , 4′-Methyl-α-pyrrolidinohexiophenone or MPHP is a stimulant compound which has been reported as a novel designer drug. It is closely related to pyrovalerone, being simply its chain-lengthened homologue. In the pyrrolidinophenone series, stimulant activity is maintained so long as the positions of the aryl, ketone and pyrrolidinyl groups are held constant, while the alkyl backbone can be varied anywhere between three and as many as seven carbons, with highest potency usually seen with the pentyl or isohexyl backbone, and a variety of substituents are tolerated on the aromatic ring.

MPHP , The toxicological detection of the new synthetic cathinone 4′-methyl-α-pyrrolidinohexanophenone (MPHP) in urine samples has been impossible, because much of MPHP is metabolized before its excretion into urine. In this study, we successfully quantified unmetabolized MPHP in urine of an autopsy case using a sensitive method by liquid chromatography–time-of-flight-mass spectrometry. The quantification method showed good linearity in the range of 1.00–100 ng/mL, and the limit of detection was 0.5 ng/mL in human urine. In the autopsy case, the concentrations of MPHP in urine, plasma, and liver tissue samples were determined to be 60.1, 32.9 ng/mL, and 63.1 ng/g, respectively. A-PVP / MDPV

4′-Methyl-α-pyrrolidinohexiophenone is a stimulant compound which has been reported as a novel designer drug. It is closely related to pyrovalerone, being simply its chain-lengthened homologue. In the pyrrolidinophenone series, stimulant activity is maintained so long as the positions of the aryl, ketone and pyrrolidinyl groups are held constant, while the alkyl backbone can be varied anywhere between three and as many as seven carbons, with highest potency usually seen with the pentyl or isohexyl backbone, and a variety of substituents are tolerated on the aromatic ring.

The toxicological detection of the new synthetic cathinone 4′-methyl-α-pyrrolidinohexanophenone in urine samples has been impossible, because much of MPHP is metabolized before its excretion into urine. In this study, we successfully quantified unmetabolized in urine of an autopsy case using a sensitive method by liquid chromatography–time-of-flight-mass spectrometry. The quantification method showed good linearity in the range of 1.00–100 ng/mL, and the limit of detection was 0.5 ng/mL in human urine. In the autopsy case, the concentrations of MPHP in urine, plasma, and liver tissue samples were determined to be 60.1, 32.9 ng/mL, and 63.1 ng/g, respectively.

quantity

10 grams, 25 grams, 50 grams, 100 grams, 250 grams, 500 grams, 1000 grams